Literature DB >> 33515224

Should Women at Lower-Than-Average Risk of Breast Cancer Undergo Less Frequent Screening?

Lydia E Pace1, Nancy L Keating1,2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33515224      PMCID： PMC8328988          DOI： 10.1093/jnci/djaa219

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Heidi D Nelson; Rongwei Fu; Bernadette Zakher; Miranda Pappas; Marian McDonagh
Journal:  JAMA       Date:  2019-09-03       Impact factor: 56.272

2.  Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care.

Authors:  Rita A Mukhtar; Jasmine M Wong; Laura J Esserman
Journal:  J Natl Compr Canc Netw       Date:  2015-06       Impact factor: 11.908

3.  Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.

Authors:  Amy Trentham-Dietz; Karla Kerlikowske; Natasha K Stout; Diana L Miglioretti; Clyde B Schechter; Mehmet Ali Ergun; Jeroen J van den Broek; Oguzhan Alagoz; Brian L Sprague; Nicolien T van Ravesteyn; Aimee M Near; Ronald E Gangnon; John M Hampton; Young Chandler; Harry J de Koning; Jeanne S Mandelblatt; Anna N A Tosteson
Journal:  Ann Intern Med       Date:  2016-08-23       Impact factor: 25.391

Review 4.  A systematic assessment of benefits and risks to guide breast cancer screening decisions.

Authors:  Lydia E Pace; Nancy L Keating
Journal:  JAMA       Date:  2014-04-02       Impact factor: 56.272

Review 5.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

Review 6.  Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

Authors:  Nora Pashayan; Antonis C Antoniou; Urska Ivanus; Laura J Esserman; Douglas F Easton; David French; Gaby Sroczynski; Per Hall; Jack Cuzick; D Gareth Evans; Jacques Simard; Montserrat Garcia-Closas; Rita Schmutzler; Odette Wegwarth; Paul Pharoah; Sowmiya Moorthie; Sandrine De Montgolfier; Camille Baron; Zdenko Herceg; Clare Turnbull; Corinne Balleyguier; Paolo Giorgi Rossi; Jelle Wesseling; David Ritchie; Marc Tischkowitz; Mireille Broeders; Dan Reisel; Andres Metspalu; Thomas Callender; Harry de Koning; Peter Devilee; Suzette Delaloge; Marjanka K Schmidt; Martin Widschwendter
Journal:  Nat Rev Clin Oncol       Date:  2020-06-18       Impact factor: 65.011
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.